Handelsinvest Investeringsforvaltning Glaukos Corp Transaction History

Handelsinvest Investeringsforvaltning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 22, 2019	SELL	$52.18 - $67.93 $2.09 Million - $2.72 Million	-40,000 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$38.13 - $68.37 $762,600 - $1.37 Million	-20,000 Reduced 33.33%	40,000 $2.6 Million
Q4 2017 Jan 30, 2018	BUY	$24.5 - $36.01 $242,550 - $356,499	9,900 Added 19.76%	60,000 $1.54 Million
Q3 2017 Oct 23, 2017	BUY	$31.26 - $42.03 $1.57 Million - $2.11 Million	50,100	50,100 $1.65 Million

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.